Industry News (Influenza)

Intravenous Flu Drug Effective Against Influenza A Virus

Published in Vaccine Weekly, October 5th, 1998

Zanamivir, a member of a new class of drugs being evaluated for use in the treatment and prevention of influenza virus infections, was effective when given intravenously in preventing experimental infection with and illness due to influenza A virus in human volunteers.

Previous studies have shown that zanamivir given by nasal spray is effective in preventing infection and in decreasing the severity and duration of illness in experimental influenza infections. Inhaled zanamivir is effective in treating acute influenza, however, this was the first study to show that the drug is also effective when administered by a systemic route in humans. That findings suggest that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-10-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry